AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Research from Sweden suggests that adding the drug tucaresol to plasmid DNA influenza vaccines could offer longer-lasting and more efficient protection against the influenza virus.
Annual flu epidemics continue to pose major health problems worldwide despite yearly vaccination efforts. Studies indicate protection offered by the current vaccine to be short-lived and only capable of targeting specific strains of the virus. Because influenza strains are highly variable, a vaccine with higher efficacy is necessary.
DNA vaccines differ from traditional vaccines in that they are entirely gene-based and are designed to target genes intracellularly. Researchers are actively pursuing plasmid DNA (pDNA) vaccines as a favorable new form of vaccination as studies show they are quick to generate (days or weeks vs. months or years), are cost-effective, and could offer long-term protection against various infectious diseases.
The pDNA vaccine specific to this study contains conserved genes from the flu virus, and although safer due to its lack of live viral strains, has shown to be weaker in inducing immune responses. Tucaresol, a drug that stimulates the immune system, is capable of interacting with molecules on the surface of T cells and was ...
Source: HighBeam Research, Drug-DNA combination could offer longer-lasting, more efficient flu...